Aptevo Therapeutics initiates Phase 1b/2 ‘RAINIER’ AML trial
PremiumThe FlyAptevo Therapeutics initiates Phase 1b/2 ‘RAINIER’ AML trial
1M ago
Aptevo Therapeutics reports Q2 EPS ($1.67) vs. ($53.95) last year
Premium
The Fly
Aptevo Therapeutics reports Q2 EPS ($1.67) vs. ($53.95) last year
1M ago
Aptevo (APVO) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Aptevo (APVO) Q2 Earnings Cheat Sheet
1M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
5M ago
Aptevo Therapeutics prices 3.4M shares at $1.35 in public offering
Premium
The Fly
Aptevo Therapeutics prices 3.4M shares at $1.35 in public offering
5M ago
Aptevo Therapeutics provides pipeline update
Premium
The Fly
Aptevo Therapeutics provides pipeline update
5M ago
Aptevo price target adjusted to $10.50 from $4.75 at Alliance Global Partners
PremiumThe FlyAptevo price target adjusted to $10.50 from $4.75 at Alliance Global Partners
7M ago
Aptevo Therapeutics trading halted, news pending
Premium
The Fly
Aptevo Therapeutics trading halted, news pending
7M ago
Aptevo Therapeutics announces 1-for-44 reverse stock split
Premium
The Fly
Aptevo Therapeutics announces 1-for-44 reverse stock split
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100